PDS BIOTECHNOLOGY CORP.PDS BIOTECHNOLOGY CORP.PDS BIOTECHNOLOGY CORP.

PDS BIOTECHNOLOGY CORP.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪97.73 M‬EUR
−1.274EUR
‪−38.91 M‬EUR
‪35.15 M‬
Beta (1Y)
2.06

About PDS Biotechnology Corporation

CEO
Frank K. Bedu-Addo
Headquarters
Princeton
Employees (FY)
25
Founded
2005
FIGI
BBG00B4W7CF0
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PDS BIOTECHNOLOGY CORP. stocks are traded under the ticker EU6.
We've gathered analysts' opinions on PDS BIOTECHNOLOGY CORP. future price: according to them, EU6 price has a max estimate of 19.30 EUR and a min estimate of 4.60 EUR. Watch EU6 chart and read a more detailed PDS BIOTECHNOLOGY CORP. stock forecast: see what analysts think of PDS BIOTECHNOLOGY CORP. and suggest that you do with its stocks.
EU6 reached its all-time high on Sep 24, 2021 with the price of 14.486 EUR, and its all-time low was 0.482 EUR and was reached on Apr 3, 2020. View more price dynamics on EU6 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track PDS BIOTECHNOLOGY CORP. financials in yearly and quarterly reports right on TradingView.
PDS BIOTECHNOLOGY CORP. is going to release the next earnings report on Aug 14, 2024. Keep track of upcoming events with our Earnings Calendar.
EU6 earnings for the last quarter are −0.28 EUR per share, whereas the estimation was −0.34 EUR resulting in a 18.18% surprise. The estimated earnings for the next quarter are −0.31 EUR per share. See more details about PDS BIOTECHNOLOGY CORP. earnings.
PDS BIOTECHNOLOGY CORP. revenue for the last quarter amounts to 0 EUR despite the estimated figure of 0 EUR. In the next quarter revenue is expected to reach 0 EUR.
EU6 net income for the last quarter is ‪−9.83 M‬ EUR, while the quarter before that showed ‪−9.87 M‬ EUR of net income which accounts for 0.47% change. Track more PDS BIOTECHNOLOGY CORP. financial stats to get the full picture.
No, EU6 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 5, 2024, the company has 25.00 employees. See our rating of the largest employees — is PDS BIOTECHNOLOGY CORP. on this list?
Like other stocks, EU6 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PDS BIOTECHNOLOGY CORP. stock right from TradingView charts — choose your broker and connect to your account.